PrecisemAb 碩準生技|最令人安心的抗體專家 PrecisemAb | A Pioneer of Anti-body Lock 我們的使命 精準的藥物，安心的治療 單株抗體藥物是現今主流的標靶治療選擇，能有效提升疾病治療效果，但傳統抗體藥物存在著全身性中和的風險，使患者產生嚴重副作用。 PrecisemAb 由 “Precise”與“mAb”組合而成，傳達我們透過「萬能抗體鎖」技術，使抗體能精準選擇疾病區域抗原，解決抗體全身性中和的問題，為病患打造最安心的治療選擇，推進人類健康福祉的企業使命。 企業簡介 PrecisemAb 由高雄醫學大學鄭添祿講座教授帶領團隊共同建立。 深耕抗體工程領域長達 25 年，鄭添祿教授成功研發獨步全球的「抗體鎖技術」，可有效提升抗體對疾病區域選擇性與降低抗體藥副作用，為抗體藥物安全性帶來革命性突破。 秉持著「以專業貢獻社會」的精神，鄭添祿教授將帶領團隊，持續為病患打造一個更安心的治療環境。 https://www.precisemab.com.tw https://en.www.precisemab.com.tw Our Mission Our name, PrecisemAb, is consisted of ‘‘Precise’’ and ‘‘mAb’’ which delivers our mission of enhancing antibody's safety through our Universal Antibody Lock technology. We deeply believe that ‘‘only when treatments are of both efficacy and safety would patients have the courage and persistance to fight for illness. ’’ We care about people's health, therefore we strive to create safer treatment solutions for patients. Universal Antibody Lock is just our first step...... Precise Antibody Drugs, Trustworthy Medical Treatments History PrecisemAb is established by Prof. Tien-Lu Cheng and his lab members. Prof. Cheng has cultivated in antibody engineering for 25 years and his original ‘‘Universal Antibody Lock’’ technology can effectively enhance antibody’s selectivity in disease area and reduce adverse effects caused by antibody drugs. This innovative technology is definitely a revolutionary breakthrough in biotechnology industry. Keeping the faith of ‘‘giving back to society with self professions’’ in mind, Prof. Cheng and PrecisemAb are committed to creating a safer and more trustworthy treatment environment for patients.

06-358 1014 生物科技、高端醫療、社區長照,基因檢驗,基因編輯,細胞製備

銨醛生物科技以提供專案實驗設計與代工服務、基礎理化設備、實驗試劑與耗材、蛋白質體分析服務、NGS服務、代謝體學分析服務等一系列生物科技服務為主要業務。我們擁有博士級團隊，致力於為客戶提供最優質的實驗分析解決方案，我們秉持著"save your safe"的精神為客戶提供最安全、最可靠的產品和服務，以確保實驗和研究的安全性。